Thursday, December 22, 2022
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), AstraZeneca PLC (AZN) and Accenture plc (ACN). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Shares of Novo Nordisk have outperformed the Zacks Large Cap Pharmaceuticals industry over the past year (+20.5% vs. +13.7%). The company has one of the broadest diabetes portfolios in the industry. Drug sales have been gaining and maintaining momentum.
Label expansion of the existing drugs is likely to boost sales further in the days ahead. Promising diabetes drug, Ozempic is off to a solid start since its launch and remains the growth engine for the company. The launch of Rybelsus also looks impressive.
However, lower realized prices in the United States, loss of exclusivity for products and stiff competition can affect sales. The supply challenges for Wegovy have hurt the stock. The patent expiry on some of the products in Novo Nordisk’s portfolio remains a woe.
(You can read the full research report on Novo Nordisk here >>>)
AstraZeneca shares have outperformed the Zacks Large Cap Pharmaceuticals industry over the past year (+16.9% vs. +13.7%). The company’s key drugs, mainly cancer medicines, Lynparza, Tagrisso and Imfinzi should keep driving revenues. Its pipeline is strong with several phase III data readouts lined up.
AstraZeneca has also been engaged in external acquisitions and strategic collaborations to boost its pipeline while investing in geographic areas of high growth like emerging markets. Cost-cutting efforts should drive earnings. The Alexion buyout strengthens its immunology franchise, adding several drugs that are boosting its top line.
However, AstraZeneca’s diabetes franchise faces stiff competition while pricing pressure hurts sales in the respiratory unit. Sales are slowing down in its key market, China.
(You can read the full research report on AstraZeneca here >>>)
Shares of Accenture have modestly underperformed the Zacks Consulting Services industry over the past year (-33.4% vs. -27.6%), with the uncertain corporate spending outlook in a cloudy macroeconomic backdrop as the biggest headwind. The company’s pricing pressure due to significant competition from strong companies like Genpact, Cognizant and Infosys, remains a concern. Global presence exposes it to foreign currency exchange rate fluctuations. Buyout-related integration risks continues to remain a concern.
However, the company has been steadily gaining traction in its outsourcing and consulting businesses backed by high demand for services that can improve operating efficiencies and save costs. The company has been strategically enhancing its cloud and digital marketing suite through buyouts and partnerships.
The company’s strong operating cash flow has helped it reward its shareholders in the form of dividend payments and share repurchases, and pursue opportunities in areas that show true potential.
(You can read the full research report on Accenture here >>>)
Other noteworthy reports we are featuring today include Chubb Limited (CB), Pioneer Natural Resources Company (PXD) and Roper Technologies, Inc. (ROP).
Director of Research
Sheraz Mian
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Today's Must Read
Novo Nordisk's (NVO) Diabetes Drugs Aid Growth Amid Rivalry
Cancer Drugs Aid AstraZeneca (AZN) Sales Amid China Impact
Fiftyfive5 Buyout Aids Accenture (ACN) Despite Low Liquidity
Featured Reports
Better Pricing, New Business Growth Drive Chubb Limited (CB)
Per the Zacks analyst, Chubb is set to grow on better pricing, new business growth and high renewal rates. Yet exposure to cat loss induces underwriting volatility while rising costs pressurize margin
Pioneer Natural (PXD) Banks On Oil-Rich Permian Basin Assets
The Zacks analyst believes that Pioneer Natural's one-million-plus high-quality acreages in the Permian Basin will drive long-term oil production growth. Yet, rising production costs are concerning.
Application Software Backs Roper (ROP) Despite Cost Woes
While the strong performance of the Application Software unit due to strength in Deltek, Vertafore and Aderant businesses bode well for Roper, the Zacks analyst is concerned about cost-inflation.
Restructuring Aids Ameriprise (AMP), Asset Outflows a Woe
Per the Zacks analyst, Ameriprise's efforts to restructure operations and focus on core businesses will support revenues. Yet, outflows in the Asset Management segment and rising costs are concerns.
Higher Nitrogen Demand and Prices Aid CF Industries (CF)
Per the Zacks analyst, CF Industries will gain from higher demand for nitrogen fertilizers in major markets. Higher nitrogen prices amid lower supply availability will also drive its margins.
Strong Demand, New Products Drive FMC Corp (FMC)
Per the Zacks analyst, strong demand for herbicides and insecticides will drive the company's top line. It should also gain from efforts to expand product portfolio through new product launches.
Cheesecake Factory (CAKE) Banks on Off-Premise Sales, Costs High
Per the Zacks analyst, Cheesecake Factory's focus on off-premise offerings and FRC-related differentiated concepts bode well. However, a rise in commodity and labor costs pose concerns.
New Upgrades
America Movil (AMX) Benefits from Increasing Subscriber Base
Per the Zacks analyst, America Movil's performance is gaining from increasing broadband client base. Focused 5G efforts and the deployment of advanced technologies are other tailwinds
Fortinet (FTNT) Rides on Product Strength, Marketing Efforts
Per the Zacks analyst, Fortinet is gaining from solid contributions of its growth-oriented products Security Fabric, cloud and SD-WAN. Increasing marketing efforts are also a positive.
U.S. Federal clients, Design Services Aids Tetra Tech (TTEK)
Per the Zacks analyst, strong momentum across U.S. Federal clients, driven by new funding for water & environment and Tetra Tech's design and engineering services will lend momentum to the company.
New Downgrades
Tyson Foods (TSN) Remains Troubled by Increasing Costs
Per the Zacks analyst, Tyson Foods is seeing high cost of goods. It saw year-over-year rise of 20-25% in cost of goods, including feed ingredients, labor, live animals and freight costs in fiscal 2022
Forex Woes, Stiff Rivalry Impedes Align's (ALGN) Growth
The Zacks analyst is worried about unfavorable foreign currency translation affecting Align Technology's financials. Stiff rivalry also remains a concern.
The Cooper Companies' (COO) Contracting Margins is a Concern
Per the Zacks analyst, the contraction of The Cooper Companies' gross and operating margins during the fiscal fourth quarter is concerning.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
AstraZeneca PLC (AZN) : Free Stock Analysis Report
Accenture PLC (ACN) : Free Stock Analysis Report
Novo Nordisk AS (NVO) : Free Stock Analysis Report
Chubb Limited (CB) : Free Stock Analysis Report
Roper Technologies, Inc. (ROP) : Free Stock Analysis Report
Pioneer Natural Resources Company (PXD) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Related Quotes
Oil is up and energy stocks are following suit. Crude oil futures were up 3% on Friday morning, partly due to expectations that Russia might cut output,. That is translating to widespread gains for companies that produce or refine the commodity. The S 500 energy sector was recently up 2%, and all 23 companies in the group were trading higher, according to FactSet data. Oil companies also dominate the list of the S 500’s biggest gainers. ConocoPhillips, Hess Corporation, Pioneer Natural Resources
FEATURE Energy stocks and oil prices were rising Friday on reports that said Russia may slash oil production in response to price caps placed on its exports. Multiple outlets reported that Russia’s Deputy Prime Minister Alexander Novak said oil production may be slashed by 500,000 to 700,000 barrels a day early next year.
Despite all the pain from Elon Musk's Twitter distractions, Tesla ranks fourth on a list of the worst S&P 500 stocks of 2022 by market-value decline.
In this piece, we will take a look at the top twelve stocks that are on Cathie Wood’s radar. For more stocks, head on over to Cathie Wood Is Loading Up On These 5 Stocks. If there’s one thing that can be said for certain in today’s highly volatile environment, it’s that 2022 has not […]
Big dividend yields can be alluring. Unfortunately, many higher-yielding dividends are at high risk of getting cut if market conditions deteriorate. Because of that, yield-focused investors should avoid that stock and instead consider buying Energy Transfer (NYSE: ET) or Verizon (NYSE: VZ).
Recognizing the right stocks is a skill that every investor needs to learn, and the sheer volume of market data, on the main indexes, on individual stocks, on and from stock analysts, can present an intimidating barrier. Fortunately, there are tools to help. The Smart Score is a data collection and collation tool from TipRanks, using an AI-powered algorithm to sort the data on every stock according to a series of factors, 8 in all, that are known for their strong correlation with future share ou
More than anything else focus on your trading and investment strategy rather than trying to find a stock that requires no effort.
Years ago, investors observed that a phenomenon dubbed the Santa Claus rally often occurred during the year-end holidays. Three Motley Fool contributors identified stocks they think could soar in a Santa Claus rally. Here's why they picked Gilead Sciences (NASDAQ: GILD), NovoCure (NASDAQ: NVCR), and Pfizer (NYSE: PFE).
The "Bomb Cyclone" that was slated to hit the country during the holidays seems an appropriate way to end 2022, which has brought little but bad tidings for investors. The artic blast has also put the focus on natural gas and fuel oil. Given this, it seems a good time to tee up a fast-growing energy producer as this weekend's covered call idea: HighPeak Energy, Inc. .
Yes, bonds have been a constant sore spot for investors this year. But that's often just the right time to get back in.
A four-day trading week will bring investors to the end of what's been a difficult year in the stock market traders won't soon forget.
More evidence for the housing market downturn came this week, as a slew of housing market readings came in worse than expected. Now, there appears to be anecdotal evidence to confirm the same. What Happened: Bill Gates has listed for sale the three-bedroom New York City apartment that he bought for his daughter Jennifer in 2018, the New York Post reported. The twist in the tale is that the asking price is $4.75 million, a discount from the $5 million at which it was purchased. The condominium, w
It’s bullish for the stock market that the average household’s equity allocation has declined as much as it has. The average household’s portfolio allocation to equities is a contrarian indicator, with higher allocations correlated with lower stock-market returns and vice versa. According to econometric tests to which I subjected this and other valuation indicators, it has one of the very best, if not the best, track records when forecasting the stock market’s real total return over the subsequent decade.
A year and a half ago, I decided to put most of my retirement portfolio into a single Vanguard fund that mimicked a 60% stock/40% bond global portfolio.
Billionaires have been able to not only acquire wealth but most have gradually built it over time. This means that many have had successful investments, which makes it natural for everyone else to wonder where they are investing or keeping … Continue reading → The post Where Do Billionaires Keep Their Money? appeared first on SmartAsset Blog.
The national savings total has dropped over $100 billion in one month — don’t run out of your savings at the wrong time.
The Dow Jones Industrial Average had a wild ride this year, facing multiple headwinds. Here's a look at the five worst performing stocks of the 30 companies the index tracks.
The unravelling of FTX founder Sam Bankman-Fried's crypto empire, Boeing's safety exemption, the housing market, and bids to refill the Strategic Petroleum Reserve (SPR) with oil are driving markets.
Does the December share price for Alibaba Group Holding Limited ( NYSE:BABA ) reflect what it's really worth? Today, we…
What follows are five surefire stocks that can help build generational wealth over the next 20 years. One such winner that can keep on winning for its shareholders is payment processor Visa (NYSE: V). In terms of credit card network market share by purchase volume, Visa is in a class of its own in the United States.